United States

Curaxis Pharmaceutical Corp (CURX.PK)

Track

Ticker: CURX.PK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Smith Patrick S Large shareholder
Transaction date
Sale
Price
98.60
Quantity 89,590 -8.1%
Value US$2,225,769
Smith Patrick S Large shareholder
Transaction date
Sale
Price
477.10
Quantity 64,852 +6.1%
Value US$374,127
GEORGE MICHAEL W Non-Executive Director
Transaction date
Purchase
Price
272.00
Quantity 73,816 -18.0%
Value US$3,573,177
Smith Patrick S Large shareholder
Transaction date
Sale
Price
0.05
Quantity 900,000 -9.2%
Value US$45,000
Smith Patrick S Large shareholder
Transaction date
Sale
Price
0.03
Quantity 150,000 -1.5%
Value US$5,100
Smith Patrick S Large shareholder
Transaction date
Sale
Price
0.10
Quantity 1,000,000 -9.1%
Value US$97,000
Leary Stephen J Non-Executive Director
Transaction date
Purchase
Price
0.05
Quantity 100,000 +22.5%
Value US$5,000
Smith Patrick S Large shareholder
Transaction date
Sale
Price
0.10
Quantity 350,000 -3.1%
Value US$35,000
Smith Patrick S Large shareholder
Transaction date
Sale
Price
0.05
Quantity 1,550,000 -12.0%
Value US$77,500
Leary Stephen J Non-Executive Director
Transaction date
Purchase
Price
0.05
Quantity 200,000 +81.8%
Value US$10,000
Geaslen Judith S.T. VP - Finance Officer
Transaction date
Purchase
Price
0.05
Quantity 200,000 +1010.1%
Value US$10,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-11-03 2011-11-02 S Sale Smith Patrick S Large shareholder
89,590 -8.1%
98.60
US$2,225,769 		89,590 -8.1% 98.60 US$2,225,769
2011-10-12 2011-10-11 S Sale Smith Patrick S Large shareholder
64,852 +6.1%
477.10
US$374,127 		64,852 +6.1% 477.10 US$374,127
2011-10-12 2011-10-10 B Purchase GEORGE MICHAEL W Non-Executive Director
73,816 -18.0%
272.00
US$3,573,177 		73,816 -18.0% 272.00 US$3,573,177
2011-10-05 2011-10-03 S Sale Smith Patrick S Large shareholder
900,000 -9.2%
0.05
US$45,000 		900,000 -9.2% 0.05 US$45,000
2011-10-05 2011-10-03 S Sale Smith Patrick S Large shareholder
150,000 -1.5%
0.03
US$5,100 		150,000 -1.5% 0.03 US$5,100
2011-10-05 2011-10-03 S Sale Smith Patrick S Large shareholder
1,000,000 -9.1%
0.10
US$97,000 		1,000,000 -9.1% 0.10 US$97,000
2011-09-20 2011-09-16 B Purchase Leary Stephen J Non-Executive Director
100,000 +22.5%
0.05
US$5,000 		100,000 +22.5% 0.05 US$5,000
2011-08-17 2011-08-15 S Sale Smith Patrick S Large shareholder
350,000 -3.1%
0.10
US$35,000 		350,000 -3.1% 0.10 US$35,000
2011-08-17 2011-08-15 S Sale Smith Patrick S Large shareholder
1,550,000 -12.0%
0.05
US$77,500 		1,550,000 -12.0% 0.05 US$77,500
2011-08-15 2011-08-15 B Purchase Leary Stephen J Non-Executive Director
200,000 +81.8%
0.05
US$10,000 		200,000 +81.8% 0.05 US$10,000
2011-08-15 2011-08-15 B Purchase Geaslen Judith S.T.

VP - Finance

Officer
200,000 +1010.1%
0.05
US$10,000 		200,000 +1010.1% 0.05 US$10,000
Explore more

More insider trading research around Curaxis Pharmaceutical Corp

More insider trades in United States
Insider trading in North America